...
首页> 外文期刊>Journal of Surgical Oncology >Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
【24h】

Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.

机译:诊断为原发性喉癌的第二个头颈部肿瘤是整体生存的指标,与整体生存较差无关:一项针对987名患者的单中心研究。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: Second primary tumors (SPTs) have been implicated in poor overall survival (OS) of head and neck squamous cell carcinomas (HNSCCs). Confusion remains regarding their actual incidence and prognostic impact. This study assessed the incidence of SPTs; the SPT diagnostic time lag; the impact on OS; and the mean annual risk. METHODS: Nine hundred eighty seven consecutive patients treated for primary larynx SCC (1967-2004) were analyzed in this study. 96.3% and 91.4% of patients reached a minimum follow-up period of 3 and 5 years. RESULTS: Two hundred eight (21.1%) patients were diagnosed with SPTs. One hundred forty three (14.5%) patients developed upper aero-digestive tract (UAD)-SPTs, 83 (8.4%) were HNSCCs, 56 (5.7%) were lung, and 4 (0.41%) were esophageal-SPTs. Survival analysis demonstrated clear superior OS rates for the UAD-SPT (P < 0.008) and HNSCC-SPT (P < 0.001) groups. A comparison of survival of subgroups showed lung/esophagus to have a poorer survival when compared to all other subgroups. OS after diagnosis of an SPT was poorer when compared with no-SPT group (P < 0.001). The mean annual risk of developing UAD-SPTs was 2.4%. CONCLUSION: These results suggest that HNSCC-SPT should not be viewed as an adverse prognostic factor. Reclassifications of UAD-SPTs into HNSCC-SPT and non-HNSCC-SPT better reflects their clinical behavior and prognosis.
机译:目的:第二原发性肿瘤(SPT)与头颈部鳞状细胞癌(HNSCC)的总体生存期(OS)差有关。关于它们的实际发生率和预后影响,仍然存在困惑。这项研究评估了SPT的发生率。 SPT诊断时间滞后;对操作系统的影响;和平均年度风险。方法:本研究分析了1967年(1967-2004年)连续治疗的987例原发性喉癌患者。 96.3%和91.4%的患者至少接受了3年和5年的随访。结果:208名(21.1%)患者被诊断患有SPTs。一百四十三(14.5%)例患者发展了上消化道(UAD)-SPTs,HNSCCs 83例(8.4%),肺部56例(5.7%),食管SPTs 4例(0.41%)。生存分析表明,UAD-SPT(P <0.008)和HNSCC-SPT(P <0.001)组的OS率明显较高。与所有其他亚组相比,对亚组的生存进行比较显示,肺/食道的生存较差。与无SPT组相比,诊断为SPT后的OS较差(P <0.001)。发生UAD-SPT的年平均风险为2.4%。结论:这些结果表明,HNSCC-SPT不应被视为不良预后因素。 UAD-SPTs重新分类为HNSCC-SPT和非HNSCC-SPT更好地反映了它们的临床行为和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号